Your browser doesn't support javascript.
loading
KPT-330 and Y219 exert a synergistic antitumor effect in triple-negative breast cancer through inhibiting NF-κB signaling.
Wen, Tiantian; Geng, Mengzhu; Bai, Enhe; Wang, Xueyuan; Miao, Hang; Chen, Zhimeng; Zhou, Hui; Wang, Jia; Shi, Jingmiao; Zhang, Yin; Lei, Meng; Zhu, Yongqiang.
Affiliation
  • Wen T; College of Life Science, Nanjing Normal University, China.
  • Geng M; College of Life Science, Nanjing Normal University, China.
  • Bai E; College of Life Science, Nanjing Normal University, China.
  • Wang X; College of Life Science, Nanjing Normal University, China.
  • Miao H; College of Science, Nanjing Forestry University, China.
  • Chen Z; College of Science, Nanjing Forestry University, China.
  • Zhou H; College of Life Science, Nanjing Normal University, China.
  • Wang J; Jiangsu Chia Tai Fenghai Pharmaceutical Co. Ltd., Nanjing, China.
  • Shi J; Jiangsu Chia Tai Fenghai Pharmaceutical Co. Ltd., Nanjing, China.
  • Zhang Y; School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, China.
  • Lei M; College of Science, Nanjing Forestry University, China.
  • Zhu Y; College of Life Science, Nanjing Normal University, China.
FEBS Open Bio ; 13(4): 751-762, 2023 04.
Article de En | MEDLINE | ID: mdl-36847599

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteur de transcription NF-kappa B / Tumeurs du sein triple-négatives Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: FEBS Open Bio Année: 2023 Type de document: Article Pays d'affiliation: Chine

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteur de transcription NF-kappa B / Tumeurs du sein triple-négatives Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: FEBS Open Bio Année: 2023 Type de document: Article Pays d'affiliation: Chine